Substance / Medication

Doxorubicin hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

50 trials linked to this intervention

50
Total Trials
35
Recruiting
6
With Results

Research Evidence

Published studies and systematic reviews

Sort:
A systematic review and economic evaluation of pegylated liposomal doxorubicin hydrochloride for ovarian cancer.
Forbes C, Wilby J, Richardson G et al. · Health Technol Assess · 2002
PMID: 12433314Meta-Analysis
Comparison of anticancer effect of Pleurotus ostreatus extract with doxorubicin hydrochloride alone and plus thermotherapy on erythroleukemia cell line.
Ebrahimi Alireza, Atashi Amir, Soleimani Masoud et al. · J Complement Integr Med · 2017
PMID: 29257758Observational
Aqueous core nanocapsules: a new solution for encapsulating doxorubicin hydrochloride.
Vrignaud Sandy, Anton Nicolas, Passirani Catherine et al. · Drug Dev Ind Pharm · 2013
PMID: 23289391Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Doxorubicin hydrochloride (substance)
SNOMED CT
90875009
UMLS CUI
C0546861

Clinical Data

This intervention maps to 19 entities in the Ltrl knowledge graph.

19
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
50
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.